STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
STRATHEP develops and validates a multimodal AI model to predict treatment response in advanced hepatocellular carcinoma. By integrating digital pathology and MRI radiomics, the project identifies patients likely to benefit from modern systemic therapies, using the RECIST 1.1 framework as the primary benchmark.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Rak wątroby leczony lekami systemowymi
- •Potwierdzenie raka wątroby biopsją w ciągu ostatniego roku lub badanie MRI wątroby z ostatnich 6 miesięcy
- •Dostęp do zaprezerwaowanej próbki tkanki z poprzedniej biopsji
- •Zgoda na wykorzystanie archiwalnych tkanek i danych do badań
✗ Disqualifies
- •Rak wątroby, który nie był leczony lekami systemowymi
- •Inne nowotwory wątroby, w tym rak przewodu żółciowego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 7, 2026
- Sex
- No restrictions
Locations (5)
Hôpital Universitaire de Bruxelles
Anderlecht, Belgium
Imelda Ziekenhuis
Bonheiden, Belgium
AZ Sint-Lucas Brugge
Bruges, Belgium
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
UZ Leuven
Leuven, Belgium
Trial contact
Jeroen Dekervel, MD PhD
Sofie De Meulder, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.